Frequency of liver test increases on abiraterone acetate in men with castrate-resistant prostate cancer (CRPC): Natural history, management, and outcome.

被引：0
|
作者：
Colomba, Emeline
Marret, Gregoire
Baciarello, Giulia
Massard, Christophe
Loriot, Yohann
Albiges, Laurence
Carton, Edith
Alexandre, Jerome
Huillard, Olivier
Culine, Stephane
Fizazi, Karim
机构：
[1] Univ Paris Sud, Gustave Roussy Inst Oncol, Villejuif, France
[2] St Louis Hosp, Paris, France
[3] Gustave Roussy Canc Campus, Villejuif, France
[4] Inst Gustave Roussy, Villejuif, France
[5] Univ Paris 05, Hop Cochin, CARPEM, AP HP, Paris, France
[6] Paris Descartes Univ, Cochin Hosp, Immunomodulatory Therapies Multidisciplinary Stud, AP HP,CARPEM, Paris, France
[7] Hosp St Louis, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.332
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
332
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Retreatment of Men With Metastatic Castrate-Resistant Prostate Cancer With Abiraterone
    Leibowitz-Amit, Raya
    Alimohamed, Nimira
    Vera-Badillo, Francisco E.
    Seah, Jo-An
    Templeton, Arnoud J.
    Knox, Jennifer J.
    Tannock, Ian F.
    Sridhar, Srikala S.
    Joshua, Anthony M.
    PROSTATE, 2014, 74 (14): : 1462 - 1464
  • [2] Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome
    Colomba, Emeline
    Marret, Gregoire
    Baciarello, Giulia
    Lavaud, Pernelle
    Massard, Christophe
    Loriot, Yohann
    Albiges, Laurence
    Carton, Edith
    Alexandre, Jerome
    Huillard, Olivier
    Culine, Stephane
    Fizazi, Karim
    EUROPEAN JOURNAL OF CANCER, 2020, 129 : 117 - 122
  • [3] Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone
    Efstathiou, Eleni
    Titus, Mark
    Tsavachidou, Dimitra
    Tzelepi, Vassiliki
    Wen, Sijin
    Anh Hoang
    Molina, Arturo
    Chieffo, Nicole
    Smith, Lisa A.
    Karlou, Maria
    Troncoso, Patricia
    Logothetis, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 637 - 643
  • [4] Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC)
    Humphreys, Michael R.
    Fernandes, Kimberly A.
    Sridhar, Srikala S.
    JOURNAL OF CANCER, 2013, 4 (04): : 304 - 314
  • [5] Management of castrate-resistant prostate cancer in older men
    Ged, Yasser
    Horgan, Anne M.
    JOURNAL OF GERIATRIC ONCOLOGY, 2016, 7 (02) : 57 - 63
  • [6] Response to ketoconazole (keto) or docetaxel (D) following clinical progression on abiraterone acetate (AA) in castrate-resistant prostate cancer (CRPC).
    Aggarwal, Rahul Raj
    Formaker, Carl
    Small, Eric Jay
    Molina, Arturo
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [7] Response to ketoconazole (keto) or docetaxel (D) following clinical progression on abiraterone acetate (AA) in castrate-resistant prostate cancer (CRPC)
    Aggarwal, Rahul Raj
    Formaker, Carl
    Small, Eric Jay
    Molina, Arturo
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experience
    Chan, Johan
    Yap, Shi Yin
    Fong, Yian Ching
    Lim, Heng Chi
    Toh, Chee Keong
    Ng, Quan Sing
    Rajasekaran, Tanujaa
    Chua, Melvin
    Lee, Lui Shiong
    Wong, Alvin
    Loh, Ker Yun
    Chow, Marcus
    Wong, Siew Wei
    Kanesvaran, Ravindran
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (01) : 75 - 79
  • [9] A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer
    George, Daniel J.
    Halabi, Susan
    Heath, Elisabeth I.
    Sartor, A. Oliver
    Sonpavde, Guru P.
    Das, Devika
    Bitting, Rhonda L.
    Berry, William
    Healy, Patrick
    Anand, Monika
    Winters, Carol
    Riggan, Colleen
    Kephart, Julie
    Wilder, Rhonda
    Shobe, Kellie
    Rasmussen, Julia
    Milowsky, Matthew I.
    Fleming, Mark T.
    Bearden, James
    Goodman, Michael
    Zhang, Tian
    Harrison, Michael R.
    McNamara, Megan
    Zhang, Dadong
    LaCroix, Bonnie L.
    Kittles, Rick A.
    Patierno, Brendon M.
    Sibley, Alexander B.
    Patierno, Steven R.
    Owzar, Kouros
    Hyslop, Terry
    Freedman, Jennifer A.
    Armstrong, Andrew J.
    CANCER, 2021, 127 (16) : 2954 - 2965
  • [10] Use of "intracrine androgen signaling signature" to predict benefit from abiraterone acetate (AA) in patients with castrate-resistant prostate cancer (CRPC)
    Efstathiou, E.
    Tu, S.
    Aparicio, A.
    Hoang, A.
    Wen, S.
    Troncoso, P.
    Smith, L. A.
    Chieffo, N.
    Molina, A.
    Logothetis, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345